{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T03:13:40Z","timestamp":1776222820703,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U20A2018"],"award-info":[{"award-number":["U20A2018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Outstanding Medical Academic Leader Program","award":["2019LJ22"],"award-info":[{"award-number":["2019LJ22"]}]},{"name":"Shanghai Sailing Program","award":["20YF1428700"],"award-info":[{"award-number":["20YF1428700"]}]},{"name":"Shanghai Chenguang Program","award":["20CG23"],"award-info":[{"award-number":["20CG23"]}]},{"name":"Shanghai Pujiang Program","award":["22PJ1410100"],"award-info":[{"award-number":["22PJ1410100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Inhaled NO is a selective pulmonary vasodilator proven to be therapeutic for patients with pulmonary artery hypertension (PAH). The most common NO delivery system in clinical practice is cylinder-based, but unfortunately limited by its high costs, complicated delivery, and the requirement of an extensive supply chain, leaving vast unmet medical needs globally.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To address the need for rapid, affordable, and safe production of nitric oxide (NO) for in-home inhalation therapy in patients with PAH. We developed a novel portable device to derive NO from a nitrite complex solution with a copper(II)-ligand catalyst, and further examined its effectiveness in a porcine model of PAH. This model was established by using female Bama miniature pig and induced by monocrotaline (MCT) administration.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>This generator could rapidly and safely produce therapeutic NO at concentrations ranging from 0 to 100 parts per million (ppm) with the least disproportionated nitrogen dioxide (NO<jats:sub>2<\/jats:sub>) and byproducts. It could effectively alleviate pulmonary arterial pressure (PAP) and pulmonary vascular resistance (PVR) in piglets with PAH, without causing major physiologic disruptions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our electrochemical NO generator is able to produce the desired NO doses for pulmonary vasodilation in a safe and sustainable way, with low costs, which paves the way for its subsequent clinical trials in the patient with PAH and other common cardiopulmonary conditions with a high disease burden around the world.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-022-02686-6","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T10:06:26Z","timestamp":1671098786000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["An electrochemical nitric oxide generator for in-home inhalation therapy in pulmonary artery hypertension"],"prefix":"10.1186","volume":"20","author":[{"given":"Yiwei","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanhao","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuoming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0206-9066","authenticated-orcid":false,"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"key":"2686_CR1","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1161\/CIR.0000000000000329","volume":"132","author":"SH Abman","year":"2015","unstructured":"Abman SH, Hansmann G, Archer SL, Ivy DD, Adatia I, Chung WK, et al. Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society. Circulation. 2015;132:2037\u201399. https:\/\/doi.org\/10.1161\/CIR.0000000000000329.","journal-title":"Circulation."},{"key":"2686_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1161\/CIRCULATIONAHA.111.026591","volume":"125","author":"RJ Barst","year":"2012","unstructured":"Barst RJ, McGoon MD, Elliott CG, Foreman AJ, Miller DP, Ivy DD. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Circulation. 2012;125:113\u201322. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.026591.","journal-title":"Circulation."},{"key":"2686_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1542\/peds.105.1.14","volume":"105","author":"MC Walsh-Sukys","year":"2000","unstructured":"Walsh-Sukys MC, Tyson JE, Wright LL, Bauer CR, Korones SB, Stevenson DK, et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics. 2000;105:14\u201320. https:\/\/doi.org\/10.1542\/peds.105.1.14.","journal-title":"Pediatrics."},{"key":"2686_CR4","first-page":"51","volume":"154","author":"LJ Ignarro","year":"1991","unstructured":"Ignarro LJ, Ross G, Tillisch J. Pharmacology of endothelium-derived nitric oxide and nitrovasodilators. West J Med. 1991;154:51\u201362.","journal-title":"West J Med"},{"key":"2686_CR5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/00000542-199303000-00005","volume":"78","author":"CG Frostell","year":"1993","unstructured":"Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapol WM. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology. 1993;78:427\u201335. https:\/\/doi.org\/10.1097\/00000542-199303000-00005.","journal-title":"Anesthesiology."},{"key":"2686_CR6","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1056\/NEJM200002173420704","volume":"342","author":"RH Clark","year":"2000","unstructured":"Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J Med. 2000;342:469\u201374. https:\/\/doi.org\/10.1056\/NEJM200002173420704.","journal-title":"N Engl J Med"},{"key":"2686_CR7","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1172\/JCI2736","volume":"101","author":"A Fox-Robichaud","year":"1998","unstructured":"Fox-Robichaud A, Payne D, Hasan SU, Ostrovsky L, Fairhead T, Reinhardt P, et al. Inhaled NO as a viable antiadhesive therapy for ischemia\/reperfusion injury of distal microvascular beds. J Clin Invest. 1998;101:2497\u2013505. https:\/\/doi.org\/10.1172\/JCI2736.","journal-title":"J Clin Invest"},{"key":"2686_CR8","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/s0022-5223(96)70364-1","volume":"111","author":"H Date","year":"1996","unstructured":"Date H, Triantafillou AN, Trulock EP, Pohl MS, Cooper JD, Patterson GA. Inhaled nitric oxide reduces human lung allograft dysfunction. J Thorac Cardiovasc Surg. 1996;111:913\u20139. https:\/\/doi.org\/10.1016\/s0022-5223(96)70364-1.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2686_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/thorax.58.4.289","volume":"58","author":"K Vonbank","year":"2003","unstructured":"Vonbank K, Ziesche R, Higenbottam TW, Stiebellehner L, Petkov V, Schenk P, et al. Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD. Thorax. 2003;58:289\u201393. https:\/\/doi.org\/10.1136\/thorax.58.4.289.","journal-title":"Thorax."},{"key":"2686_CR10","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/s0003-4975(01)03406-3","volume":"73","author":"MN Kavarana","year":"2002","unstructured":"Kavarana MN, Pessin-Minsley MS, Urtecho J, Catanese KA, Flannery M, Oz MC, et al. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg. 2002;73:745\u201350. https:\/\/doi.org\/10.1016\/s0003-4975(01)03406-3.","journal-title":"Ann Thorac Surg"},{"key":"2686_CR11","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1172\/JCI89741","volume":"127","author":"GJ Kato","year":"2017","unstructured":"Kato GJ, Steinberg MH, Gladwin MT. Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Invest. 2017;127:750\u201360. https:\/\/doi.org\/10.1172\/JCI89741.","journal-title":"J Clin Invest"},{"key":"2686_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1161\/01.cir.87.2.447","volume":"87","author":"JD Jr Roberts","year":"1993","unstructured":"Jr Roberts JD, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM. Inhaled nitric oxide in congenital heart disease. Circulation. 1993;87:447\u201353. https:\/\/doi.org\/10.1161\/01.cir.87.2.447.","journal-title":"Circulation."},{"key":"2686_CR13","doi-asserted-by":"publisher","first-page":"2003895","DOI":"10.1002\/advs.202003895","volume":"8","author":"F Lisi","year":"2021","unstructured":"Lisi F, Zelikin AN, Chandrawati R. Nitric oxide to fight viral infections. Adv Sci (Weinh). 2021;8:2003895. https:\/\/doi.org\/10.1002\/advs.202003895.","journal-title":"Adv Sci (Weinh)"},{"key":"2686_CR14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.4187\/respcare.03308","volume":"60","author":"DR Todd Tzanetos","year":"2015","unstructured":"Todd Tzanetos DR, Housley JJ, Barr FE, May WL, Landers CD. Implementation of an inhaled nitric oxide protocol decreases direct cost associated with its use. Respir Care. 2015;60:644\u201350. https:\/\/doi.org\/10.4187\/respcare.03308.","journal-title":"Respir Care"},{"key":"2686_CR15","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.4187\/respcare.08856","volume":"66","author":"S Gianni","year":"2021","unstructured":"Gianni S, Carroll RW, Kacmarek RM, Berra L. Inhaled nitric oxide delivery systems for mechanically ventilated and nonintubated patients: a review. Respir Care. 2021;66:1021\u20138. https:\/\/doi.org\/10.4187\/respcare.08856.","journal-title":"Respir Care"},{"key":"2686_CR16","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.chest.2020.02.016","volume":"158","author":"SD Nathan","year":"2020","unstructured":"Nathan SD, Flaherty KR, Glassberg MK, Raghu G, Swigris J, Alvarez R, et al. Inhaled nitric oxide in subjects at risk of pulmonary hypertension associated with pulmonary fibrosis. Chest. 2020;158:637\u201345. https:\/\/doi.org\/10.1016\/j.chest.2020.02.016.","journal-title":"Chest."},{"key":"2686_CR17","doi-asserted-by":"publisher","first-page":"294ra107","DOI":"10.1126\/scitranslmed.aaa3097","volume":"7","author":"B Yu","year":"2015","unstructured":"Yu B, Muenster S, Blaesi AH, Bloch DB, Zapol WM. Producing nitric oxide by pulsed electrical discharge in air for portable inhalation therapy. Sci Transl Med. 2015;7:294ra107. https:\/\/doi.org\/10.1126\/scitranslmed.aaa3097.","journal-title":"Sci Transl Med"},{"key":"2686_CR18","unstructured":"Center for Drug Evaluation and Research. Application number: 202860Orig1s000. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2019\/202860Orig1s000Approv.pdf. Accessed 20 Sep 2022."},{"key":"2686_CR19","unstructured":"The ARRIVE guidelines 2.0: author checklist. https:\/\/arriveguidelines.org\/resources\/author-checklists. Accessed 4 Nov 2022."},{"key":"2686_CR20","unstructured":"Biocompatibility evaluation of breathing gas pathways in healthcare applications \u2014 Part 3: Tests for emissions of volatile organic compounds (VOCs) (ISO 18562-3:2017). https:\/\/www.iso.org\/standard\/62894.html. Accessed 20 Sep 2022."},{"key":"2686_CR21","unstructured":"Biocompatibility evaluation of breathing gas pathways in healthcare applications \u2014 Part 1: Evaluation and testing within a risk management process (ISO 18562-1:2017). https:\/\/www.iso.org\/standard\/62892.html. Accessed 20 Sep 2022."},{"key":"2686_CR22","unstructured":"Biocompatibility evaluation of breathing gas pathways in healthcare applications \u2014 Part 2: Tests for emissions of particulate matter (ISO 18562-2:2017). https:\/\/www.iso.org\/standard\/62893.html. Accessed 20 Sep 2022."},{"key":"2686_CR23","unstructured":"The National Institute for Occupational Safety and Health (NIOSH). NITROGEN DIOXIDE. https:\/\/www.cdc.gov\/niosh\/pel88\/10102-44.html. Accessed 20 Sept 2022."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02686-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-022-02686-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02686-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T10:07:50Z","timestamp":1671098870000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-022-02686-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2686"],"URL":"https:\/\/doi.org\/10.1186\/s12916-022-02686-6","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"assertion":[{"value":"24 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was approved by the Animal Ethics Committee of Shanghai Children's Medical Center. All animal procedures and care were conducted with approved animal protocols in accordance with the Institutional Animal Care and Use Committee (IACUC) guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"481"}}